🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01-20
Trial ID
NCT06804850
Treatments Being Tested
In this study, the investigators will use Tislelizumab combined with LM-302...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2026-04-21
Trial ID
NCT07569068
Treatments Being Tested
This is a phase II/III, multi-center, open-label, 3-arm, randomized control...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2022-04-01
Trial ID
NCT05245474
Treatments Being Tested
This study is a single-center, prospective, open-label, randomized controll...
Status
Completed
Location
Fourth Hospital of Hebei Medical University
Start Date
2021-09-01
Trial ID
NCT05086627
Treatments Being Tested
Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor world...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-04-01
Trial ID
NCT07531979
Treatments Being Tested
To evaluate the safety and preliminary efficacy of preoperative chemotherap...
Status
Recruiting
Location
The affiliated hospital of Qingdao university
Start Date
2025-06-01
Trial ID
NCT06647680
Refining neoadjuvant chemoimmunotherapy and establishing predictive biomark...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-15
Trial ID
NCT07271992
Treatments Being Tested
Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Status
Not Yet Recruiting
Location
Tangdu Hospital, Fourth Military Medical University
Start Date
2026-07-10
Trial ID
NCT07678580
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
This prospective, multi-center, phase II randomized controlled trial will e...
Status
Recruiting
Location
Johannes Gutenberg-University Clinic, Mainz, Germany 1.Dept. Medicine, Prof. Peter R. Galle
Start Date
2025-07-23
Trial ID
NCT06940388
Treatments Being Tested